Mon, January 30, 2023
Sun, January 29, 2023
Fri, January 27, 2023
Thu, January 26, 2023

Michael Ulz Upgraded (CABA) to Buy and Held Target at $16 on, Jan 27th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-16-on-jan-27th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Michael Ulz of Morgan Stanley, Upgraded "Cabaletta Bio, Inc." (CABA) to Buy and Held Target at $16 on, Jan 27th, 2023.

Michael has made no other calls on CABA in the last 4 months.



There are 2 other peers that have a rating on CABA. Out of the 2 peers that are also analyzing CABA, 0 agree with Michael's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Michael


  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $14 on, Tuesday, January 3rd, 2023
  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $12 on, Friday, November 11th, 2022

Publication Contributing Sources